molecules molecules molecules molecules molecules molecules



Small molecule CD73 inhibitor

CD73 is the primary enzymatic producer of immunosuppressive adenosine in the tumor microenvironment, and high CD73 expression is associated with significantly poorer prognosis in several tumor types.

immunosuppression graphic


ATP is released from tumor cells in response to cellular stresses.

Enzymatic action of CD39 and CD73 convert extracellular ATP into adenosine, which elicits immunosuppressive effects on tumor-infiltrating immune cells.

immune cell activation graphic

Immune cell activation

Quemliclustat is a potent and selective small molecule inhibitor of CD73 that has been shown to block the production of adenosine.

The reduction of adenosine restores immune function.

tumor cell death graphic

Immune-Mediated Tumor Cell Death

Once the immunosuppressive effects of adenosine are removed, activation of antitumor immune cells may be restored resulting in tumor cell death.